Global Genome Editing/Genome Engineering Market Insights, Size and Growth Forecast To 2030

COVID-19
Genome Editing/Genome Engineering Market Size, Share & Trends Analysis By Product & Service, By Application, By Technology, By End-Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030
Request COVID-19
impact analysis

Genome Editing/Genome Engineering Market Size, Share & Trends Analysis By Product & Service, By Application, By Technology, By End-Users, Regional Outlook, Competitive Strategies and Segment Forecasts to 2030

Published: Feb 2022 Base Year: 2021 Report ID: BIOT2201
Available Format: Historical Data: 2019 - 2020 Number of Pages: 1 - 265
Category : Biotechnology


Global Genome Editing/Genome Engineering Market is projected to be worth USD 25.3 billion by 2030

According to SPER Market Research, the Genome Editing/Genome Engineering Market is estimated to reach USD 25.3 billion by 2030 with a CAGR of 19.5%. Academies & government research centre used genome engineering before, now it is diversified into clinical & diagnostic fields too, this leads to the escalation of the market.

Impact of COVID-19 on the Genome Editing/Genome Engineering Market 
The outbreak of COVID-19 has boosted the investment of pharmaceutical companies and biopharmaceutical companies, and genomic market player in research & development and in vaccine.

Scope of the report:
 Report Metric Details
 Market size available for years 2019-2030
 Base year considered 2021
 Forecast period 2022-2030
 Segments coveredBy Product & Service, By Application, By Technology, By End Users, By Region
 Geographies covered North America, Europe, Asia Pacific, Latin America, Middle East, Africa
 Companies CoveredAgilent Technologies, Beam Therapeutics, Bluebird Bio, Caribou Biosciences., Cellectis S.A, Creative Biogene, CRISPR Therapeutics AG, Editas Medicine, GenScript, Integrated DNA Technologies, Intellia Therapeutics, Lonza, Merck KGaA, New England Biolabs, OriGene Technologies, PerkinElmer, Precision Biosciences, Recombinetics, Regeneron Pharmaceuticals, Sangamo Therapeutics, Synthego, Tecan Life Sciences, Thermo Fisher Scientific, Transposagen, Biopharmaceuticals, Vigene Biosciences

Driver: Increase in funding
In the recent years there is increase in the government funding globally in the genomic research this allows academies & research centre to work on genomic engineering. 

Restraints: Off-target effect of CRISPR Technology 
CRISPR-Cas9 has an Off-target effects, The mismatch tolerance capacity of CRISPR-Cas9 is one to three, beyond this leads to off-target nuclease activity; it can be the reason for mutations in these genes in turn oncogenesis. 

Opportunity: widespread use of Genome Engineering
Due to better efficacy, compliance, economical, optimization of therapy the demand for personalized medicine increasing worldwide. Personalized medicine markets offering lots of opportunities to the genomic market.



Challenges: Costly equipment
At the beginning, this might be costly for the academic research to afford, but in later stage the advanced technology is going to build affordable instruments, so it is a short term challenges for this market.
Global Genome Editing/Genome Engineering Market, by Product & Service: Based on the Product & Service, Global Genome Editing/Genome Engineering Market is segmented as; Reagents & consumables, Services, Software & systems

Global Genome Editing/Genome Engineering Market, by Application: 
Based on the Application, Global Genome Editing/Genome Engineering Market is segmented as; Cell Line Engineering, Diagnostic applications, Drug discovery & development, Genetic Engineering, Other applications

Global Genome Editing/Genome Engineering Market, by Technology:
Based on the Technology, Global Genome Editing/Genome Engineering Market is segmented as; Antisense, CRISPR, TALEN, ZFN, Other technologies.

Global Genome Editing/Genome Engineering Market, by End-Users:
Based on the End-Users, Global Genome Editing/Genome Engineering Market is segmented as; Academic & Government Research Institutes, Biotechnology companies, Pharmaceutical companies.

Global Genome Editing/Genome Engineering Market, by Region:
North America owns the prime share of this market; it is because of growing exploitation of genetically modified crops, gene therapy, government grants and funding.


1. Introduction

2. Research Methodology

3. Executive Summary

4. Market Overview
4.1. Introduction
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.2.4. Challenges
4.3. COVID-19 Impact on the Genome Editing/Genome Engineering Market 
4.4. Market Trends

5. Global Genome Editing/Genome Engineering Market, by Product & Service, 2019-2030 (USD Million)
5.1. Reagents & consumables
5.2. Services
5.3. Software & systems

6. Global Genome Editing/Genome Engineering Market, by Application, 2019-2030 (USD Million)
6.1. Cell Line Engineering
6.2. Diagnostic applications
6.3. Drug discovery & development
6.4. Genetic Engineering
6.5. Other applications

7. Global Genome Editing/Genome Engineering Market, by Technology, 2019-2030 (USD Million)
7.1. Antisense
7.2. CRISPR
7.3. TALEN
7.4. ZFN
7.5. Other technologies

8. Global Genome Editing/Genome Engineering Market, by End-Users, 2019-2030 (USD Million)
8.1. Academic & Government Research Institutes
8.2. Biotechnology companies
8.3. Pharmaceutical companies

9. Global Genome Editing/Genome Engineering Market, by Region, 2019-2030 (USD Million)
9.1. North America
9.1.1. US
9.1.2. Canada
9.2. Europe
9.2.1. France 
9.2.2. Germany 
9.2.3. Italy 
9.2.4. Spain 
9.2.5. UK
9.2.6. Rest of the Europe
9.3. Asia Pacific 
9.3.1. China
9.3.2. India 
9.3.3. Japan
9.3.4. Rest of Asia Pacific
9.4. Latin America
9.5. Middle East 
9.6. Africa

10. Competitive Landscape
10.1. Introduction
10.2. Market Share Analysis, By Key Players 
10.3. Competitive Scenario 
10.3.1. Product Launches
10.3.2. Partnerships, Collaborations and Agreements
10.3.3. Acquisitions
10.3.4. Expansions
10.3.5. Other Developments

11. Company Profiles
11.1. Agilent Technologies
11.2. Beam Therapeutics 
11.3. Bluebird Bio 
11.4. Caribou Biosciences.
11.5. Cellectis S.A
11.6. Creative Biogene 
11.7. CRISPR Therapeutics AG 
11.8. Editas Medicine
11.9. GenScript 
11.10. Integrated DNA Technologies
11.11. Intellia Therapeutics 
11.12. Lonza 
11.13. Merck KGaA
11.14. New England Biolabs 
11.15. OriGene Technologies 
11.16. PerkinElmer 
11.17. Precision Biosciences
11.18. Recombinetics
11.19. Regeneron Pharmaceuticals 
11.20. Sangamo Therapeutics 
11.21. Synthego
11.22. Tecan Life Sciences 
11.23. Thermo Fisher Scientific
11.24. Transposagen Biopharmaceuticals
11.25. Vigene Biosciences 

12. Appendix

SPER Market Research’s methodology uses great emphasis on primary research to ensure that the market intelligence insights are up to date, reliable and accurate. Primary interviews are done with players involved in each phase of a supply chain to analyze the market forecasting. The secondary research method is used to help you fully understand how the future markets and the spending patterns look likes.

The report is based on in-depth qualitative and quantitative analysis of the Global Product Market. The quantitative analysis involves the application of various projection and sampling techniques. The qualitative analysis involves primary interviews, surveys, and vendor briefings.  The data gathered as a result of these processes are validated through experts opinion. Our research methodology entails an ideal mixture of primary and secondary initiatives.

SPER-Methodology-1

SPER-Methodology-2

SPER-Methodology-3

Not able to find what you are looking for? Need customization in the existing report?
Click Here
PLACE AN ORDER
  • 15% off
     
    $ 4250
  • 20% off
             
    $ 5650
  • 25% off
         
    $ 7450
Pre-Purchase Inquiry
SEND AN INQUIRY
NEED CUSTOMIZATION?
Request Customization
100% Secure Payment

SPER American Express
SPER VISA
SPER Master Card
SPER Mestro
SPER Paypal
SPER CCAvenues

Join SPER Panel

Our Global Clients

Our data-driven insights have influenced the strategy of 200+ reputed companies across the globe.
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB
SPER-Astellas Pharma
SPER-Citi Bank
SPER-Microsoft
SPER-EY
SPER-Sanofi
SPER-p&g
SPER-Johnson & Johnson
SPER-SIEMENS
SPER-LOREAL
SPER-Pfizer
SPER-IPSOS
SPER-Heineken
SPER-IQVIA
SPER-Kankar IMRB

SPER

Market Research

We are the leading, full-service global market research and consulting company.

Certificates
iso-1 iso-1
Secure Payments
SPER Payment Options
Connect with us